150 related articles for article (PubMed ID: 11461068)
1. Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer.
Helle SI; Geisler J; Anker GB; Leirvaag B; Holly JM; Lønning PE
Br J Cancer; 2001 Jul; 85(2):147-51. PubMed ID: 11461068
[TBL] [Abstract][Full Text] [Related]
2. Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients.
Helle SI; Holly JM; Tally M; Hall K; Vander Stappen J; Lønning PE
Int J Cancer; 1996 Aug; 69(4):335-9. PubMed ID: 8797879
[TBL] [Abstract][Full Text] [Related]
3. Influence of treatment with onapristone on the IGF-system in breast cancer patients.
Helle SI; Jonat W; Giurescu M; Ekse D; Holly JM; Lønning PE
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):159-63. PubMed ID: 9719450
[TBL] [Abstract][Full Text] [Related]
4. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
5. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
Helle SI; Anker GB; Tally M; Hall K; Lønning PE
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
[TBL] [Abstract][Full Text] [Related]
6. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
Krassas GE; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen JW; Flyvbjerg A
J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841
[TBL] [Abstract][Full Text] [Related]
7. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
Lawrence JB; Conover CA; Haddad TC; Ingle JN; Reid JM; Ames MM; Suman VJ; Marks RS; Erlichman C; Hartmann LC
Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
[TBL] [Abstract][Full Text] [Related]
10. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
[TBL] [Abstract][Full Text] [Related]
12. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.
Frystyk J; Grøfte T; Skjaerbaek C; Orskov H
J Clin Endocrinol Metab; 1997 Sep; 82(9):3124-7. PubMed ID: 9284756
[TBL] [Abstract][Full Text] [Related]
13. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
[TBL] [Abstract][Full Text] [Related]
14. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
15. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
[TBL] [Abstract][Full Text] [Related]
16. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer.
Frost VJ; Helle SI; Lønning PE; van der Stappen JW; Holly JM
J Clin Endocrinol Metab; 1996 Jun; 81(6):2216-21. PubMed ID: 8964854
[TBL] [Abstract][Full Text] [Related]
18. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer.
Reed MJ; Christodoulides A; Koistinen R; Seppälä M; Teale JD; Ghilchik MW
Int J Cancer; 1992 Sep; 52(2):208-12. PubMed ID: 1381703
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
